Mr. Stanton J. Rowe, also known as Stan, now CEO of the NXT Biomedical Incubator has been the Chief Scientific Officer of Edwards Lifesciences Corp. since 2008 and serves as its Corporate Vice President of Advanced Technology.
Mr. Rowe served as a Scientific Advisor at Ascent Biomedical Ventures.
He Founded Percutaneous Valve Technologies (sold to Edwards).
Mr. Rowe served as the President and Chief Executive Officer of Percutaneous Valve Technologies Inc. (PVT).
He served as the Corporate Vice President of Business Development and Strategic Planning at Datascope Corp. Prior to this, Mr. Rowe served as a Vice President of Business Development at Johnson & Johnson’s Interventional Systems Division (JJIS), responsible for Johnson & Johnson’s coronary stent development efforts. At JJIS and the related Cordis Corporation, he held a variety of positions with increasing levels of responsibility, including heading Johnson & Johnson’s Business Development, Advanced Technology, Worldwide Clinical Research and Marketing groups. Mr. Rowe joined Cordis after having held several positions in product management for various medical device companies.
He serves as a Director of InSeal Medical Ltd. Mr. Rowe also serves as Director of Remon Medical Ltd. He serves as a Board Member of NeuralAnalytics and the Discovery Science Center in Orange County. He serves as a Director of Zift Medical, LLC. He served as a Director of Biomerix Corporation. He holds a Bachelor’s Degree from the University of Alabama.